The global cardiac biomarkers market was worth US$ 7.5 Billion in 2019. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2020-2025.
To learn more about this market, visit us at: https://www.imarcgroup.com/cardiac-biomarkers-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Changing lifestyles, hectic schedules and shifting dietary patterns have resulted in the frequent occurrence of chronic diseases such as diabetes and CVDs. This, along with growing awareness among the majority of the population regarding the importance of early diagnosis of these chronic diseases, is driving the demand for cardiac biomarkers. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.c